CYPOR is a novel and independent prognostic biomarker of recurrence‐free survival in triple‐negative breast cancer patients-Reference-Cited by-同舟云学术

CYPOR is a novel and independent prognostic biomarker of recurrence‐free survival in triple‐negative breast cancer patients

Published:2018-11-07 Issue:3 Volume:144 Page:631-640
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Pedersen Martin H.¹,Hood Brian L.²^ORCID,Ehmsen Sidse¹^ORCID,Beck Hans C.³^ORCID,Conrads Thomas P.²⁴,Bak Martin⁵,Ditzel Henrik J.¹⁶^ORCID,Leth‐Larsen Rikke¹⁷^ORCID

Affiliation:

1. Department of Cancer and Inflammation ResearchInstitute of Molecular Medicine, University of Southern Denmark Odense Denmark

2. Womens Health Integrated Research Center at Inova Health System; Gynecologic Cancer Center of ExcellenceHenry Jackson Foundation for the Advancement of Military Medicine Annandale VA

3. Department of Clinical Biochemistry and PharmacologyOdense University Hospital Odense Denmark

4. Inova Schar Cancer InstituteInova Center for Personalized Health Fairfax VA

5. Department of PathologyOdense University Hospital Odense Denmark

6. Department of OncologyOdense University Hospital Odense Denmark

7. Department of Regional Health ResearchUniversity of Southern Denmark Odense Denmark

Funder

Kræftens Bekæmpelse

Det Frie Forskningsråd

Publisher

Wiley

Subject

Cancer Research,Oncology